EFSD/Sanofi Pilot Research Grants for Innovative Measurement of Diabetes Outcomes
EFSD/Sanofi Pilot Research Grants for Innovative Measurement of Diabetes Outcomes
2020
Amber van der Heijden: Amsterdam UMC - Netherlands
Improvement of CVD risk stratification: an innovative method for optimal timing of ECG monitoring
2019
Miguel Castelo-Branco: University of Coimbra - Portugal
Integrating multimodal imaging with metabolomics and oxidative stress outcomes in diabetes
Moshe Phillip: Schneider Children’s Medical Center - Petah Tikva, Israel
Use of big-data to evaluate continuous glucose monitoring related diabetes outcome metrics
Guadalupe Sabio: CNIC - Madrid, Spain
Diabetes associated with their liver disease
Amir Tirosh: Sheba Medical Center - Ramat Gan, Israel
Patient reported outcomes and ambulatory glucose profiles in a virtual type 1 diabetes clinic
2018
Tali Cukierman-Yaffe: Sheba Medical Centre - Ramat-Gan, Israel
A technology based model for physical capacity (gait-speed, balance and aerobic) measurement in older people with diabetes
Giuseppe Maulucci: Catholic University of the Sacred Heart - Rome, Italy
Erythrocyte membrane fluidity as a biomarker for a quantitative biological assessment of cardiovascular risk score in type 2 diabetes
Femke Rutters: VU University Medical Center - Amsterdam, Netherlands
Screened it! Validation and implementation of computerized adaptive testing for measuring patient reported outcomes in people with diabetes in diabetes care
2017
Yang De Marinis: Lund University - Malmö, Sweden
New epigenetic targets for diabetic kidney disease prediction
Cristina Hernández: Vall d’Hebron Research Institute – Barcelona, Spain
Non-invasive assessment of advanced glycation end-products (AGEs) and diabetic outcomes: an integrated pilot study
Lucia La Sala: IRCSS MultiMedica – Milan, Italy
Novel approaches to evaluate glycaemic control in the onset and management of impaired glucose tolerance and type 2 diabetes
Claire Meek: University of Cambridge - UK
Novel markers of glycaemic control in women with type 1 diabetes in pregnancy – an ancillary study from the CONCEPTT randomised clinical trial